| Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles K Ling, H Wu, AS Neish, JA Champion Journal of Controlled Release 295, 174-186, 2019 | 113 | 2019 |
| Protein nanoparticle charge and hydrophobicity govern protein corona and macrophage uptake SM Pustulka, K Ling, SL Pish, JA Champion ACS Applied Materials & Interfaces 12 (43), 48284-48295, 2020 | 107 | 2020 |
| Bioengineering bacterially derived immunomodulants: a therapeutic approach to inflammatory bowel disease L Herrera Estrada, H Wu, K Ling, G Zhang, R Sumagin, CA Parkos, ... ACS nano 11 (10), 9650-9662, 2017 | 32 | 2017 |
| Effects of PEG-based thermoresponsive polymer brushes on fibroblast spreading and gene expression LS Sefcik, A Kaminski, K Ling, A Laschewsky, JF Lutz, E Wischerhoff Cellular and Molecular Bioengineering 6, 287-298, 2013 | 26 | 2013 |
| Protein nanoparticle charge and hydrophobicity govern protein corona and macrophage uptake. ACS Appl. Mater JA Champion, SM Pustulka, K Ling, SL Pish Interfaces 12, 48284-48295, 2020 | 9 | 2020 |
| ENGINEERING THERAPEUTIC AVRA NANOPARTICLES WITH ENHANCED UPTAKE AND INTRACELLULAR DELIVERY WITH APPLICATIONS IN INFLAMMATORY BOWEL DISEASE K Ling Georgia Institute of Technology, 2018 | 1 | 2018 |
| Stapled peptides and methods thereof BH White, DS La, LJ Alfaro-Lopez, PC Ortet, SI Cappucci, Z Li, JH Mcgee, ... US Patent App. 18/568,212, 2024 | | 2024 |
| Abstract PO-036: Targeting the CBM signalosome with a MALT1 scaffolding inhibitor for treatment of non-Hodgkin lymphomas Y Yao, K Ling, H Xia, H Sun, Y Bi, J Kuai, J Wahle, W Liu, K Carson, ... Blood Cancer Discovery 5 (3_Supplement), PO-036-PO-036, 2024 | | 2024 |
| Discovery of Novel, First-in-Class Allosteric Modulators of MALT1 Scaffolding Function with Differentiated Pharmacology for NFκB-Driven Malignancies Y Yao, Y Bi, H Sun, K Ling, H Xia, J Kuai, P DePaolo, V Lafont, D Diller, ... Blood 142, 52, 2023 | | 2023 |
| Development of a novel and direct peptide Helicon࣪ inhibitor of β-catenin-TCF interaction with in vivo validation of transcriptional modulation and anti-tumor activity Y Si, B White, S Cappucci, J Ramirez, C Ponthier, E Visness, K Ling, P Du, ... Cancer Research 82 (12_Supplement), 345-345, 2022 | | 2022 |
| O-014 Bioengineering Bacterially Derived Immunomodulants: A Novel Therapeutic Approach to Inflammatory Disease J Champion, H Wu, L Estrada, K Ling, R Sumagin, C Parkos, A Neish Inflammatory Bowel Diseases 19, S8-S9, 2013 | | 2013 |
| Evaluating cellular biocompatibility on thermo‐responsive polymer brushes LS Anderson, A Kaminski, K Ling, E Wischerhoff The FASEB Journal 25, 1128.2-1128.2, 2011 | | 2011 |
